J. Bratton

发表

Computer-Assisted Brush-Biopsy Analysis for the Detection of Dysplasia in a High-Risk Barrett’s Esophagus Surveillance Population

D. Graham, N. Harpaz, J. Waye, 2011, Digestive Diseases and Sciences.

Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial

A. Marx, S. Muley, R. Conwit, 2019, The Lancet Neurology.

Ethnic differences in risk and prognostic factors for breast cancer.

P. Tartter, S. Brower, J. Bratton, 1995, Cancer.

The significance of family history for patients with carcinoma of the breast.

P. Tartter, S. Brower, J. Bratton, 1994, Journal of the American College of Surgeons.

Ethnic differences in risk and prognostic factors for breast cancer

P. Tartter, S. Brower, J. Bratton, 1995, Cancer.

Clinical Examination, Mammography, and Fine‐Needle Aspiration Cytology in the Management of Palpable Breast Masses

P. Tartter, J. Bratton, J. Samuels, 1997 .

Clinical Effects of the Self-administered Subcutaneous Complement Inhibitor Zilucoplan in Patients With Moderate to Severe Generalized Myasthenia Gravis

M. Benatar, M. Bromberg, M. Pasnoor, 2020, JAMA neurology.

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study.

G. L. Masson, W. Löscher, P. Vermersch, 2017, The Lancet. Neurology.

Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study

Adam L. Comer, Robert G. Miller, S. Demeret, 2023, The Lancet Neurology.

The efficacy of neoadjuvant chemotherapy compared to postoperative therapy in the treatment of locally advanced breast cancer.

I. Bleiweiss, P. Tartter, S. Brower, 1998, Cancer investigation.